These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 20403962)

  • 1. The presence of sodium dodecyl sulphate-stable Abeta dimers is strongly associated with Alzheimer-type dementia.
    Mc Donald JM; Savva GM; Brayne C; Welzel AT; Forster G; Shankar GM; Selkoe DJ; Ince PG; Walsh DM;
    Brain; 2010 May; 133(Pt 5):1328-41. PubMed ID: 20403962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid-β oligomerization in Alzheimer dementia versus high-pathology controls.
    Esparza TJ; Zhao H; Cirrito JR; Cairns NJ; Bateman RJ; Holtzman DM; Brody DL
    Ann Neurol; 2013 Jan; 73(1):104-19. PubMed ID: 23225543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appearance of sodium dodecyl sulfate-stable amyloid beta-protein (Abeta) dimer in the cortex during aging.
    Enya M; Morishima-Kawashima M; Yoshimura M; Shinkai Y; Kusui K; Khan K; Games D; Schenk D; Sugihara S; Yamaguchi H; Ihara Y
    Am J Pathol; 1999 Jan; 154(1):271-9. PubMed ID: 9916941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease.
    Yu L; Petyuk VA; Tasaki S; Boyle PA; Gaiteri C; Schneider JA; De Jager PL; Bennett DA
    JAMA Neurol; 2019 Jul; 76(7):818-826. PubMed ID: 31009033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct pools of beta-amyloid in Alzheimer disease-affected brain: a clinicopathologic study.
    Steinerman JR; Irizarry M; Scarmeas N; Raju S; Brandt J; Albert M; Blacker D; Hyman B; Stern Y
    Arch Neurol; 2008 Jul; 65(7):906-12. PubMed ID: 18625856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble amyloid beta levels are elevated in the white matter of Alzheimer's patients, independent of cortical plaque severity.
    Collins-Praino LE; Francis YI; Griffith EY; Wiegman AF; Urbach J; Lawton A; Honig LS; Cortes E; Vonsattel JP; Canoll PD; Goldman JE; Brickman AM
    Acta Neuropathol Commun; 2014 Aug; 2():83. PubMed ID: 25129614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathogenic aβ43 is enriched in familial and sporadic Alzheimer disease.
    Sandebring A; Welander H; Winblad B; Graff C; Tjernberg LO
    PLoS One; 2013; 8(2):e55847. PubMed ID: 23409063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of amyloid plaques integrity affects the soluble oligomers content from Alzheimer disease brains.
    Jimenez S; Navarro V; Moyano J; Sanchez-Mico M; Torres M; Davila JC; Vizuete M; Gutierrez A; Vitorica J
    PLoS One; 2014; 9(12):e114041. PubMed ID: 25485545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.
    Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR
    Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different aspects of Alzheimer's disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia.
    Thal DR; Ronisz A; Tousseyn T; Rijal Upadhaya A; Balakrishnan K; Vandenberghe R; Vandenbulcke M; von Arnim CAF; Otto M; Beach TG; Lilja J; Heurling K; Chakrabarty A; Ismail A; Buckley C; Smith APL; Kumar S; Farrar G; Walter J
    Acta Neuropathol Commun; 2019 Nov; 7(1):178. PubMed ID: 31727169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
    Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
    JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.
    Kawarabayashi T; Younkin LH; Saido TC; Shoji M; Ashe KH; Younkin SG
    J Neurosci; 2001 Jan; 21(2):372-81. PubMed ID: 11160418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Immunization with Soybean Storage Protein Containing Amyloid-β 4-10 Prevents Spatial Learning Decline.
    Kawarabayashi T; Terakawa T; Takahashi A; Hasegawa H; Narita S; Sato K; Nakamura T; Seino Y; Hirohata M; Baba N; Ueda T; Harigaya Y; Kametani F; Maruyama N; Ishimoto M; St George-Hyslop P; Shoji M
    J Alzheimers Dis; 2019; 70(2):487-503. PubMed ID: 31177217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins.
    Pham E; Crews L; Ubhi K; Hansen L; Adame A; Cartier A; Salmon D; Galasko D; Michael S; Savas JN; Yates JR; Glabe C; Masliah E
    FEBS J; 2010 Jul; 277(14):3051-67. PubMed ID: 20573181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of sodium dodecyl sulfate-stable amyloid beta-protein dimers in the hippocampus CA1 not exhibiting neurofibrillary tangle formation.
    Funato H; Enya M; Yoshimura M; Morishima-Kawashima M; Ihara Y
    Am J Pathol; 1999 Jul; 155(1):23-8. PubMed ID: 10393832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unveiling Brain Aβ Heterogeneity Through Targeted Proteomic Analysis.
    Rostagno A; Neubert TA; Ghiso J
    Methods Mol Biol; 2018; 1779():23-43. PubMed ID: 29886525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline.
    Näslund J; Haroutunian V; Mohs R; Davis KL; Davies P; Greengard P; Buxbaum JD
    JAMA; 2000 Mar 22-29; 283(12):1571-7. PubMed ID: 10735393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plaque-associated overexpression of insulin-degrading enzyme in the cerebral cortex of aged transgenic tg2576 mice with Alzheimer pathology.
    Leal MC; Dorfman VB; Gamba AF; Frangione B; Wisniewski T; Castaño EM; Sigurdsson EM; Morelli L
    J Neuropathol Exp Neurol; 2006 Oct; 65(10):976-87. PubMed ID: 17021402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial Danish dementia: co-existence of Danish and Alzheimer amyloid subunits (ADan AND A{beta}) in the absence of compact plaques.
    Tomidokoro Y; Lashley T; Rostagno A; Neubert TA; Bojsen-Møller M; Braendgaard H; Plant G; Holton J; Frangione B; Révész T; Ghiso J
    J Biol Chem; 2005 Nov; 280(44):36883-94. PubMed ID: 16091362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated by beta protein immunostaining.
    Yamaguchi H; Hirai S; Morimatsu M; Shoji M; Ihara Y
    Acta Neuropathol; 1988; 76(6):541-9. PubMed ID: 3059748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.